Advertisement
Screener

VERU INC. (VERU) Dividends Per Share

2.8 / 5 stars · 68/120 Roast Me

VERU INC. Dividends Per Share

VERU INC. (VERU) reported Dividends Per Share of $0.21 per share for the 12-month period ending 2014-09-30, per its 10-K filed 2016-12-12.

Discontinued › Income Statement › Earnings Per Share

us-gaap:CommonStockDividendsPerShareDeclared · last filed 2016-12-12

  • VERU INC. common stock, dividends, per share, declared for the quarter ending 2014-09-30 was $0.00, a 100.00% decline year-over-year.
  • VERU INC. common stock, dividends, per share, declared for the quarter ending 2014-06-30 was $0.00.
  • VERU INC. common stock, dividends, per share, declared for the quarter ending 2014-03-31 was $0.07, a 0.00% change year-over-year.
  • VERU INC. common stock, dividends, per share, declared for the quarter ending 2013-12-31 was $0.14, a 16.67% increase year-over-year.
  • VERU INC. common stock, dividends, per share, declared for fiscal 2014 was $0.21, a 19.23% decline from fiscal 2013.
  • VERU INC. common stock, dividends, per share, declared for fiscal 2013 was $0.26, a 18.18% increase from fiscal 2012.
  • VERU INC. common stock, dividends, per share, declared for fiscal 2012 was $0.22, a 10.00% increase from fiscal 2011.
  • VERU INC. common stock, dividends, per share, declared for fiscal 2011 was $0.20.
Period endCommon Stock, Dividends, Per Share, Declared 0 monthCommon Stock, Dividends, Per Share, Declared 3 monthCommon Stock, Dividends, Per Share, Declared 6 monthCommon Stock, Dividends, Per Share, Declared 9 monthCommon Stock, Dividends, Per Share, Declared 12 month
2014-09-30$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-12
$0.00
derived: sum of 2 quarters · filed 2016-12-12
$0.07
derived: sum of 3 quarters · filed 2016-12-12
$0.21
10-K · filed 2016-12-12
2014-06-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-07-30
$0.07
derived: sum of 2 quarters · filed 2015-07-30
$0.21
10-Q · filed 2015-07-30
$0.28
derived: sum of 4 quarters · filed 2015-07-30
2014-03-31$0.07
10-Q · filed 2015-04-30
$0.21
10-Q · filed 2015-04-30
$0.28
derived: sum of 3 quarters · filed 2015-04-30
2014-03-24$0.07
10-Q · filed 2014-05-01
2013-12-31$0.14
10-Q · filed 2015-02-03
$0.21
derived: sum of 2 quarters · filed 2015-02-03
2013-12-12$0.07
10-Q · filed 2014-02-03
2013-10-04$0.07
10-K · filed 2013-12-03
2013-09-30$0.07
derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-02
$0.07
derived: sum of 2 quarters · filed 2015-12-02
$0.14
derived: sum of 3 quarters · filed 2015-12-02
$0.26
10-K · filed 2015-12-02
2013-07-15$0.07
10-Q · filed 2013-08-01
2013-06-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-07-31
$0.07
derived: sum of 2 quarters · filed 2014-07-31
$0.19
10-Q · filed 2014-07-31
2013-03-31$0.07
10-Q · filed 2014-05-01
$0.19
10-Q · filed 2014-05-01
2013-03-27$0.07
10-Q · filed 2013-05-02
$0.19
derived: sum of 2 quarters · filed 2014-02-03
$0.25
derived: sum of 3 quarters · filed 2014-12-02
$0.25
derived: sum of 4 quarters · filed 2014-12-02
2012-12-31$0.12
10-Q · filed 2014-02-03
$0.18
derived: sum of 2 quarters · filed 2014-12-02
$0.18
derived: sum of 3 quarters · filed 2014-12-02
$0.24
derived: sum of 4 quarters · filed 2014-12-02
2012-10-05$0.06
10-K · filed 2012-12-04
2012-09-30$0.06
derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-02
$0.06
derived: sum of 2 quarters · filed 2014-12-02
$0.12
derived: sum of 3 quarters · filed 2014-12-02
$0.22
10-K · filed 2014-12-02
2012-07-12$1700000.00
10-Q · filed 2012-07-31
2012-06-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-08-01
$0.06
derived: sum of 2 quarters · filed 2013-08-01
$0.16
10-Q · filed 2013-08-01
2012-03-31$0.06
10-Q · filed 2013-05-02
$0.16
10-Q · filed 2013-05-02
2011-12-31$0.10
10-Q · filed 2013-01-30
2011-09-30$0.20
10-K · filed 2013-12-03

Similar stocks

Stock NameCountryMarket CapPE Ratio
Kairos Pharma, LTD. (KAPA)United States$0.041B
SCYNEXIS INC (SCYX)United States$0.045B
PDS Biotechnology Corp (PDSB)United States$0.045B
Incannex Healthcare Inc. (IXHL)$0.040B-22.32
Grace Therapeutics, Inc. (GRCE)$0.046B-1.83
Karyopharm Therapeutics Inc. (KPTI)United States$0.039B-0.98
Edesa Biotech, Inc. (EDSA)Canada$0.039B
Werewolf Therapeutics, Inc. (HOWL)United States$0.047B
CervoMed Inc. (CRVO)United States$0.038B-1.39
Celularity Inc (CELU)United States$0.038B-0.34